Outcomes of secondary cytoreductive surgery for patients with platinum-sensitive recurrent ovarian cancer
Most women with advanced epithelial ovarian cancer develop recurrent disease despite maximal surgical cytoreduction and adjuvant platinum-based chemotherapy. In observational studies secondary cytoreductive surgery has been associated with improved survival, however its use is controversial, because there are concerns that the improved outcomes may reflect selection bias rather than the superiority of secondary surgery.
Source: American Journal of Obstetrics and Gynecology - Category: OBGYN Authors: Allison Gockley, Alex Melamed, Angel Cronin, Michael A. Bookman, Robert A. Burger, Mihaela C. Cristae, Jennifer J. Griggs, Gina Mantia-Smaldone, Ursula A. Matulonis, Larissa A. Meyer, Joyce Niland, David M. O ’Malley, Alexi A. Wright Tags: Original Research: Gynecology Source Type: research
More News: Cancer | Cancer & Oncology | Chemotherapy | Epithelial Cancer | OBGYN | Ovarian Cancer | Ovaries | Study | Women